Anne Hathaway has invested in food tech company EVERY, marking the first B2B investment for the actor.
EVERY creates animal-free proteins with a lower environmental impact, including the world’s first animal-free pepsin and egg proteins.
The company aims to ‘accelerate the world’s transition to animal-free protein.’
“The need to transform our food system has never been clearer or more urgent.
“An important piece of the puzzle is in nature-equivalent animal proteins, such as EVERY has been developing. I’m proud to back this vision of a better future.”
Investments in platforms like EVERY’s—which uses fermentation to “brew” proteins without animals or the climate impacts of factory farms—totalled $1.7 billion (£1.3 billion) in a recent period.
EVERY’s egg proteins are Vegan Society Certified and crafted with significantly less land, water and greenhouse gas emissions than comparable conventional animal proteins, the company said.
EVERY CEO, Arturo Elizondo, said:
“We are thrilled to partner with visionary investors like Anne to drive forward our plans to reimagine the way we feed and nourish the world.
“Ultimately, our vision is to deliver animal-free protein to everyone, everywhere—and help set the table for the better food future we all deserve.”
Hathaway was drawn to impact investing after making lifestyle adjustments to reduce her consumption of meat and single-use plastics, and to embrace a zero waste approach.
The actor joins the likes of EVERY investors Bloom8, McWin Food Systems Fund, Temasek, TO Ventures, Grosvenor, ZX Ventures and others who have collectively infused over $230 million (£186 million) in EVERY to date.
Image: minglemediatv (flickr)